Agoracom: Small Cap Investment - Zenith Epigenetics - Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Exempt Distribution - November 16, 2022

posted on Dec 06, 2022 12:32PM

816,667 Units (one common share and two warrants) @ $0.79 CAN =$652,239.00

40,833 common shares @ $0.79 CAN = $32,612.00

Warrants expire 2027-11-16 @ $0.79 CAN

3 Purchasers - USA

Total = $684.851.00

Koo

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply